The American Chemical Society, or ACS, has appointed Jane Aldrich, Ph.D., as a fellow. ACS will honor Aldrich, along with the rest of its 2019 fellows — a cohort of 70 from organizations as diverse as GlaxoSmithKline, NASA and Massachusetts Institute of Technology — at its National Meeting & Expo, August 25–29 in San Diego.
Aldrich, a professor in the department of medicinal chemistry at the University of Florida College of Pharmacy, received the distinguished recognition, first, for her excellence and leadership that has impacted science and education.
Her research on analogs of opioid peptides has been continuously funded by the National Institute on Drug Abuse for more than 25 years, and she has been the principal investigator of over $14 million in research grants. Additionally, she has supervised more than 25 graduate students, 20 rotation and undergraduate students and 20 postdoctoral and research associates across her career at four different universities.
Secondly, ACS fellowship calls for excellence and leadership in service to the organization. Aldrich has been affiliated with the ACS since 1986. In that time, she has served as medicinal chemistry division chair and councilor, organized webinars, meetings and symposia and served on ACS committees and on the editorial advisory board of the “Journal of Medicinal Chemistry.” She and her research group have made more than 35 presentation at ACS meetings.